Search research articles
Contact Us
Filters
Showing results (161-170 of 168) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 168 results.
Open Forum Infectious Diseases
|
June 24, 2026
The Evolving Epidemiology of Invasive Pneumococcal Disease in Australian Children: A Multicentre Retrospective Observational Study
Phoebe C M Williams, Annaleise Howard Jones, Robert Duguid, et al.
Reproductive Biomedicine Online
|
December 23, 2003
Infertility therapy-associated multiple pregnancies (births): an ongoing epidemic
Eli Y Adashi, Pedro N Barri, Richard Berkowitz, et al.
Journal of Medicinal Chemistry
|
May 4, 2021
Discovery of Potent and Brain-Penetrant Tau Tubulin Kinase 1 (TTBK1) Inhibitors that Lower Tau Phosphorylation In Vivo
Tamara Halkina, Jaclyn L Henderson, Edward Y Lin, et al.
Journal of Natural Products
|
September 3, 2016
Analogues of Marine Guanidine Alkaloids Are in Vitro Effective against Trypanosoma cruzi and Selectively Eliminate Leishmania (L.) infantum Intracellular Amastigotes
Ligia F Martins, Juliana T Mesquita, Erika G Pinto, et al.
The Lancet. Microbe
|
February 28, 2026
Characterisation of Bordetella pertussis virulence and macrolide resistance in Australia by targeted culture-independent sequencing: a genomic epidemiology study
Winkie Fong, Rebecca J Rockett, Kingsley King-Gee Tam, et al.
The Lancet. Microbe
|
June 23, 2025
Diagnostic and phylogenetic perspectives of the 2023 Murray Valley encephalitis virus outbreak in Australia: an observational study
Annaleise R Howard-Jones, Jackie E Mahar, Kate Proudmore, et al.
Clinical Immunology (Orlando, Fla.)
|
December 20, 2022
Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19
Weng Hua Khoo, Katherine Jackson, Chansavath Phetsouphanh, et al.
Journal of Medicinal Chemistry
|
May 7, 2024
Discovery and Preclinical Characterization of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of Multiple Sclerosis
Martin K Himmelbauer, Bekim Bajrami, Rebecca Basile, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 168) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 168 results.
Open Forum Infectious Diseases
|
June 24, 2026
The Evolving Epidemiology of Invasive Pneumococcal Disease in Australian Children: A Multicentre Retrospective Observational Study
Phoebe C M Williams, Annaleise Howard Jones, Robert Duguid, et al.
Reproductive Biomedicine Online
|
December 23, 2003
Infertility therapy-associated multiple pregnancies (births): an ongoing epidemic
Eli Y Adashi, Pedro N Barri, Richard Berkowitz, et al.
Journal of Medicinal Chemistry
|
May 4, 2021
Discovery of Potent and Brain-Penetrant Tau Tubulin Kinase 1 (TTBK1) Inhibitors that Lower Tau Phosphorylation In Vivo
Tamara Halkina, Jaclyn L Henderson, Edward Y Lin, et al.
Journal of Natural Products
|
September 3, 2016
Analogues of Marine Guanidine Alkaloids Are in Vitro Effective against Trypanosoma cruzi and Selectively Eliminate Leishmania (L.) infantum Intracellular Amastigotes
Ligia F Martins, Juliana T Mesquita, Erika G Pinto, et al.
The Lancet. Microbe
|
February 28, 2026
Characterisation of Bordetella pertussis virulence and macrolide resistance in Australia by targeted culture-independent sequencing: a genomic epidemiology study
Winkie Fong, Rebecca J Rockett, Kingsley King-Gee Tam, et al.
The Lancet. Microbe
|
June 23, 2025
Diagnostic and phylogenetic perspectives of the 2023 Murray Valley encephalitis virus outbreak in Australia: an observational study
Annaleise R Howard-Jones, Jackie E Mahar, Kate Proudmore, et al.
Clinical Immunology (Orlando, Fla.)
|
December 20, 2022
Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19
Weng Hua Khoo, Katherine Jackson, Chansavath Phetsouphanh, et al.
Journal of Medicinal Chemistry
|
May 7, 2024
Discovery and Preclinical Characterization of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of Multiple Sclerosis
Martin K Himmelbauer, Bekim Bajrami, Rebecca Basile, et al.
Page
of 17